SEC Form 4 · accession 0001127602-17-006143

VARIAN MEDICAL SYSTEMS INC · VAR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP and Pres. Oncology Sys.

Period of report

Feb 10, 2017

Accepted (ET)

Feb 14, 2017 · 6:27 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000203527

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non Qualified Stock Option (Right to Buy)^F1	$80.40	Feb 10, 2017	A	25,170	A	—	Feb 10, 2024	Common Stock	25,170	25,170	D
Restricted Stock Units^F4,F2,F3	—	Feb 10, 2017	A	5,050	A	—	—	Common Stock	5,050	16,033	D

F1Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
F2Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F3The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date.
F4Includes restricted stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Restricted stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share.